EARLY EVALUATION OF HISTOLOGICAL MARKERS OF FIBROSIS AND CELLULAR PROLIFERATION IN LIVER TRANSPLANT PATIENTS WITH HCV RECURRENCE

被引：0
|
作者：
Mensa, L. [1 ]
Marino, Z. [1 ]
Crespo, G. [1 ]
Lens, S. [1 ]
Miquel, R. [2 ]
Carrion, J. [1 ]
Perez-del-Pulgar, S. [1 ]
Forns, X. [1 ]
Navasa, M. [1 ]
机构：
[1] Hosp Clin Barcelona, CIBERehd, IDIBAPS, Liver Unit, Barcelona, Spain
[2] Hosp Clin Barcelona, CIBERehd, IDIBAPS, Dept Pathol, Barcelona, Spain
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
10.1016/S0168-8278(13)60171-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
169
引用
收藏
页码：S75 / S75
页数：1
相关论文
共 50 条
  • [41] HCV GENOTYPES IN LIVER-TRANSPLANT PATIENTS
    ZEIN, NN
    RAKELA, J
    POTERUCHA, J
    WIESNER, RH
    KROM, RAF
    PERSING, DH
    GASTROENTEROLOGY, 1994, 106 (04) : A1013 - A1013
  • [42] Histological and clinical outcome of HCV liver transplanted patients
    Morelli, MC
    Polifemo, AM
    Mimmo, RA
    DeVergon, E
    Casanova, S
    Mazzco, C
    Marchetto, S
    Roda, E
    GUT, 1997, 41 : A239 - A239
  • [43] Liver retransplantation for HCV recurrence: A national survey of practice patterns in liver transplant programs
    Burton, JR
    Rosen, HR
    GASTROENTEROLOGY, 2004, 126 (04) : A674 - A674
  • [44] IL28B POLYMORPHISMS ARE ASSOCIATED WITH HISTOLOGICAL RECURRENCE AND TREATMENT RESPONSE FOLLOWING LIVER TRANSPLANTATION IN PATIENTS WITH HCV WITH HCV INFECTION
    Charlton, Michael R.
    Thompson, Alexander J.
    Veldt, Bart J.
    Watt, Kymberly D.
    Tillmann, Hans L.
    Poterucha, John J.
    Heimbach, Julie
    Goldstein, David B.
    McHutchison, John G.
    HEPATOLOGY, 2010, 52 (04) : 320A - 320A
  • [45] HCV GENOTYPES, POST TRANSPLANT HEPATITIS (PTH) AND HCV RECURRENCE AFTER LIVER-TRANSPLANTATION
    BELLI, LS
    SILINI, E
    ALBERTI, A
    BELLATI, G
    FESCE, E
    GELOSA, F
    ASTI, L
    RONDINARA, GF
    DECARLIS, L
    BELLI, L
    IDEO, G
    HEPATOLOGY, 1994, 20 (04) : A131 - A131
  • [46] Biochemical and histological predictors of acute cellular rejection (ACR) versus HCV recurrence.
    Montalbano, M
    Neff, GW
    Yamashiki, N
    Molina, E
    Bejarano, P
    Khaled, A
    Garcia, M
    Sobhonslidsuk, A
    Kirby, L
    Schiff, E
    Tzakis, A
    HEPATOLOGY, 2002, 36 (04) : 657A - 657A
  • [47] Early evaluation of regulatory T cells to predict severity of HCV recurrence after liver transplantation
    Ghazal, Kaldoun
    Olivier, Morales
    Barjon, Clement
    Dahlqvist, Geraldine
    Aoudjehane, Lynda
    Ouaguia, Laurissa
    Calmus, Yvon
    Nadira, Delhem
    Conti, Filomena
    HEPATOLOGY, 2014, 60 : 461A - 461A
  • [48] Histological markers of humoral rejection in renal transplant patients
    Valente, M.
    Furian, L.
    Marino, S.
    Rigotti, P.
    De Fazio, N.
    Cardillo, M.
    Cusinato, R.
    Aiello, F. B.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (06) : 1827 - 1829
  • [49] Liver transplantation for HCV cirrhosis in HIV-HCV coinfected patients. Evaluation of antiretroviral toxicity and of HCV recurrence.
    Samuel, D
    Vittecoq, D
    Duclos-Vallee, JC
    Feray, C
    Teicher, E
    Azoulay, D
    Saliba, F
    Afonso, AMR
    Ichai, P
    Castaing, D
    Adam, R
    Guettier, C
    Dussaix, E
    Bismuth, H
    HEPATOLOGY, 2002, 36 (04) : 231A - 231A
  • [50] Fibrosis progression on protocol liver biopsies in patients with or without antiviral treatment for HCV recurrence following liver transplantation (LT)
    De Martin, Eleonora
    Boninsegna, Sara
    Senzolo, Marco
    Guido, Maria
    Russo, Francesco P.
    Germani, Giacomo
    Gambato, Martina
    Masier, Annalisa
    Zanus, Giacomo
    Burra, Patrizia
    TRANSPLANT INTERNATIONAL, 2008, 21 : 6 - 6
12345